Investor's Business Daily on MSN18m
Amgen Rebounds, Shaking Off 'Overdone' Fears Tied To Its Weight-Loss ShotAmgen stock rebounded Wednesday, shaking off "overdone" fears that its monthly weight-loss shot, MariTide, causes excessive bone mineral density loss.Please watch the video at Investors.com - How Novo ...
Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...
Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...
Hosted on MSN4h
Patients Reveal Another "Nightmare" Ozempic Side EffectBetter known by Novo Nordisk's brand names Ozempic and Wegovy (the former of which is indicated only for type 2 diabetes), ...
EU antitrust regulators have asked pharma rivals and customers for feedback in four business areas in light of Novo Holdings' ...
open image in gallery A box of Ozempic made by Novo Nordisk is seen at a pharmacy in London, (REUTERS/Hollie Adams/File Photo ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
Hims & Hers is launching a tracker of GLP-1 shortages to push back against the FDA's recent moves to end compounding copycats ...
Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback